Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension.
暂无分享,去创建一个
C. Ayers | E. Halm | A. Pandey | Sandeep R. Das | N. Kaplan | W. Vongpatanasin | P. Raheja | Stephanie K Brinker | Angela L. Price | D. Arbique | Debbie Arbique
[1] S. Toennes,et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis , 2013, Journal of hypertension.
[2] J. Ceral,et al. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy , 2011, Hypertension Research.
[3] H. Krum,et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial , 2010, The Lancet.
[4] Daniel W. Jones,et al. A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research , 2008 .